Results 151 to 160 of about 31,319 (237)

Does faster aspart improve time in range in children with type 1 diabetes with glycaemia close to target on insulin pump therapy?

open access: yesDiabetic Medicine, Volume 43, Issue 8, August 2026.
Abstract Aims To evaluate whether faster insulin aspart (FIA) improves time in range (TIR) compared with standard insulin aspart (SIA) in children and adolescents with type 1 diabetes achieving glycaemia close to target treated with continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM).
Kowalczyk‐Korcz Emilia   +3 more
wiley   +1 more source

Advancing Early‐Stage Type 1 Diabetes Care: Future Focused Pathways for Identification, Screening, Diagnosis, and Monitoring

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 8, Page 6836-6849, August 2026.
ABSTRACT Background Although international guidelines provide recommendations for screening and monitoring of early‐stage type 1 diabetes (T1D), navigating the care pathway can still be difficult for individuals, caregivers, and healthcare professionals (HCPs). These challenges are exacerbated by variations in healthcare systems, gaps in communication,
Chantal Mathieu   +14 more
wiley   +1 more source

Hashimoto's disease: Struma lymphomatosa

open access: yesJournal of British Surgery, 1954
R H, HEPTINSTALL, H H, EASTCOTT
openaire   +2 more sources

Development of Chimeric Antigen Receptor‐Modified NK Cells for the Immunotherapy of Adult T‐Cell Leukemia/Lymphoma

open access: yesEuropean Journal of Haematology, Volume 117, Issue 2, Page 481-491, August 2026.
ABSTRACT Adult T‐cell leukemia/lymphoma (ATL) is an aggressive hematological malignancy with a poor prognosis and limited therapeutic options. ATL cells exhibit aberrant surface glycosylation patterns resulting from dysregulated glycosyltransferase expression, representing a potentially tumor‐specific therapeutic target.
Yuichiro Uchida   +7 more
wiley   +1 more source

A Study on the Association Between Treatment Response to Atezolizumab Plus Bevacizumab Combination Therapy for Advanced Hepatocellular Carcinoma and Gut Microbiota. [PDF]

open access: yesMicroorganisms
Tanaka Y   +17 more
europepmc   +1 more source

Long‐Term Cancer and Mortality After Thymectomy

open access: yesEuropean Journal of Neurology, Volume 33, Issue 8, August 2026.
In a propensity score‐matched study comparing 398 thymectomy patients with 398 cardiothoracic controls over 10 years, thymectomy was not associated with excess all‐cause mortality (HR 0.78; 95% CI 0.54–1.13) or new malignancy (4.3% in both groups). Indication‐stratified analysis revealed heterogeneity: thymic malignancy carried significantly higher ...
Shahar Shelly   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy